FDA ANDA · ANDA209040
TAFLUPROST
Sponsor: SANDOZ
What this page does not claim
A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.
APPLICATION
ANDA209040
TYPE
ANDA
ORIGINAL APPROVAL
2022-01-28
LATEST ACTION
2026-10-08
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription
Products
TAFLUPROSTPrescription
TAFLUPROST 0.0015% · SOLUTION/DROPS · OPHTHALMIC
Approval history
2026-10-08Labeling · Supplement 2 · standardAP
Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →